Prelude Therapeutics develops precision cancer medicines, including targeted protein degraders and antibody drug conjugates, for patients with underserved cancers. It last closed at $3.23 on Nov 20, down 0.77% on the day. The next earnings report for PRLD is expected around Tue, Mar 9, 2027. For the quarter ended Sep 2026, PRLD reported EPS of -$0.12 on revenue of $5.6M, with revenue down 13.1% from a year ago. Over its last 8 reports the stock moved an average of 7.1% the session after earnings. Over the last 12 months PRLD insiders bought $25.0M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is PRLD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PRLD.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PRLDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PRLD · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 14% below its 20 day and 19% below its 50 day average. It is 28% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 35), near oversold. The nearest support is the swing low (Oct 16) at $3.18, and the nearest resistance the Pivot R1 at $3.30.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 8.6%/day
Key levels
$6.8352 week high+111.5%
$4.44100 day average+37.5%
$4.13200 day average+27.9%
$3.8350 day average+18.6%
$3.78Swing high (Oct 21)+17.0%
$3.6720 day average+13.6%
$3.30Pivot R1+2.2%
$3.23Pivot+0.0%
$3.23Last close
$3.18Swing low (Oct 16)−1.5%
$3.17Pivot S1−1.9%
$1.2952 week low−60.1%
Indicators
RSI (14)
35.46
Weak, oversold below 30
Neutral
MACD
-0.17
Below its signal line
Bearish
Stochastic
5.0
Near the bottom of its range
Oversold
ADX (14)
16.1
No clear trend
Williams %R
-93.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-127.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−10.3%
Change over 10 sessions
Bearish
ATR (14)
$0.28
Typical daily range, 8.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Turning down
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityNormal, 24.1%/day
Key levels
$6.8352 week high+111.5%
$4.44100 day average+37.5%
$4.13200 day average+27.9%
$3.8350 day average+18.6%
$3.78Swing high (Oct 21)+17.0%
$3.6720 day average+13.6%
$3.30Pivot R1+2.2%
$3.23Pivot+0.0%
$3.23Last close
$3.18Swing low (Oct 16)−1.5%
$3.17Pivot S1−1.9%
$1.2952 week low−60.1%
Indicators
RSI (14)
42.39
Middle of its range
Neutral
MACD
-0.15
Below its signal line
Bearish
Stochastic
6.8
Near the bottom of its range
Oversold
ADX (14)
32.5
Trending up
Williams %R
-98.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-105.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−29.6%
Change over 10 sessions
Bearish
ATR (14)
$0.78
Typical daily range, 24.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for PRLD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PRLD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PRLD usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PRLDHow many large options trades hit PRLD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PRLD in the last 90 days.
From SEC Form 4 filings by PRLD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRLD is in one of them and how their past PRLD trades turned out.
Prelude Therapeutics is a precision oncology company based in Wilmington, Delaware. It discovers and develops cancer medicines, including small molecule inhibitors, protein degraders, and antibody drug conjugates, aimed at cancers with limited treatment options. Its pipeline targets driver mutations in blood cancers and solid tumors, such as a JAK2V617F inhibitor for myeloproliferative neoplasms and a KAT6A degrader for advanced breast cancer. The company serves cancer patients and is advancing its candidates through clinical trials.